• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

镰状细胞病患者感染新型冠状病毒肺炎的临床表现及结局：来自加纳孔福·阿诺凯教学医院的病例系列

Clinical presentations and outcomes of COVID-19 infection in sickle cell disease patients: Case series from Komfo Anokye teaching hospital, Ghana.

作者信息

Hardy Yasmine O, Amenuke Divine A Y, Abukari Yakubu, Oti-Acheampong Alexander, Hutton-Mensah Kojo, Amoah-Dankwah James, Amoabeng Kontoh Samuel, Danso Kwabena Asimeng, Berchie Patrick Opoku, Otu-Ansah Caleb

机构信息

Department of Medicine Komfo Anokye Teaching Hospital/School of Medical Sciences Kwame Nkrumah University of Science & Technology Kumasi Ghana.

Department of Medicine Komfo Anokye Teaching Hospital Kumasi Ghana.

出版信息

Clin Case Rep. 2020 Dec 31;9(2):1018-1023. doi: 10.1002/ccr3.3719. eCollection 2021 Feb.

DOI:10.1002/ccr3.3719
PMID:33598289
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7869395/
Abstract

Patients with sickle cell disease and COVID-19 may not have a more dire outcome than the general population. Nevertheless, they may present with acute chest syndrome and other sickle cell crises which should be aggressively managed.

摘要

镰状细胞病患者感染新冠病毒后的病情可能并不比普通人群更严重。然而，他们可能会出现急性胸部综合征和其他镰状细胞危象，对此应积极进行治疗。

相似文献

1
Clinical presentations and outcomes of COVID-19 infection in sickle cell disease patients: Case series from Komfo Anokye teaching hospital, Ghana.镰状细胞病患者感染新型冠状病毒肺炎的临床表现及结局：来自加纳孔福·阿诺凯教学医院的病例系列
Clin Case Rep. 2020 Dec 31;9(2):1018-1023. doi: 10.1002/ccr3.3719. eCollection 2021 Feb.
2
Research knowledge transfer to improve the care and support of adolescents with sickle cell disease in Ghana.研究知识转移以改善加纳镰状细胞病青少年的护理和支持。
Health Expect. 2022 Oct;25(5):2515-2524. doi: 10.1111/hex.13573. Epub 2022 Jul 31.
3
Hypertrophic tonsils in sickle cell patients in ghana.加纳镰状细胞病患者的扁桃体肥大
J West Afr Coll Surg. 2012 Jul;2(3):1-11.
4
COVID- 19 and sickle cell disease: autopsy findings of three deaths at the 37 Military Hospital, Accra, Ghana.COVID-19 与镰状细胞病：加纳阿克拉 37 军医院三例死亡的尸检结果。
Pan Afr Med J. 2022 Apr 25;41:332. doi: 10.11604/pamj.2022.41.332.30035. eCollection 2022.
5
Organ damage in sickle cell disease study (ORDISS): protocol for a longitudinal cohort study based in Ghana.镰状细胞病研究中的器官损伤（ORDISS）：基于加纳的纵向队列研究方案。
BMJ Open. 2017 Aug 28;7(8):e016727. doi: 10.1136/bmjopen-2017-016727.
6
Establishing a Sickle Cell Disease Registry in Africa: Experience From the Sickle Pan-African Research Consortium, Kumasi-Ghana.在非洲建立镰状细胞病登记处：来自加纳库马西镰状细胞病泛非研究联盟的经验
Front Genet. 2022 Feb 24;13:802355. doi: 10.3389/fgene.2022.802355. eCollection 2022.
7
The African AIDS case definition and HIV serology in medical in-patients at Komfo Anokye Teaching Hospital, Kumasi, Ghana.加纳库马西Komfo Anokye教学医院住院患者的非洲艾滋病病例定义及HIV血清学
West Afr J Med. 1994 Apr-Jun;13(2):98-101.
8
Chest radiography patterns of COVID-19 pneumonia in Kumasi, Ghana.加纳库马西地区 COVID-19 肺炎的胸部 X 线摄影表现。
Ghana Med J. 2020 Dec;54(4):264-268. doi: 10.4314/gmj.v54i4.9.
9
Evaluation of Metabolic Syndrome and Its Associated Risk Factors in Type 2 Diabetes: A Descriptive Cross-Sectional Study at the Komfo Anokye Teaching Hospital, Kumasi, Ghana.加纳库马西科福莫耶教学医院 2 型糖尿病患者代谢综合征及其相关危险因素评估：一项描述性横断面研究。
Biomed Res Int. 2019 May 2;2019:4562904. doi: 10.1155/2019/4562904. eCollection 2019.
10
Preparing a young palliative care unit for the COVID-19 pandemic in a teaching hospital in Ghana.在加纳的一家教学医院为 COVID-19 大流行准备一个年轻的姑息治疗病房。
Palliat Support Care. 2020 Aug;18(4):400-402. doi: 10.1017/S1478951520000498.

引用本文的文献

1
Case Report: Obstetric and COVID-19-Related Morbidity and Mortality in Three Patients with Sickle Hemoglobinopathy.病例报告：三位镰状血红蛋白病患者的产科和与 COVID-19 相关的发病率和死亡率。
Am J Trop Med Hyg. 2024 Apr 23;110(6):1198-1200. doi: 10.4269/ajtmh.23-0761. Print 2024 Jun 5.
2
Impact of the SARS-CoV-2 infection in individuals with sickle cell disease: an integrative review.2019冠状病毒病感染对镰状细胞病患者的影响：一项综合综述。
Front Med (Lausanne). 2023 May 2;10:1144226. doi: 10.3389/fmed.2023.1144226. eCollection 2023.
3
A case of hyperhemolysis syndrome in sickle cell disease and concomitant COVID-19.

本文引用的文献

1
Low morbidity and mortality with COVID-19 in sickle cell disease: A single center experience.镰状细胞病患者感染新冠病毒后的低发病率和死亡率：单中心经验
EJHaem. 2020 Aug 30;1(2):608-614. doi: 10.1002/jha2.87. eCollection 2020 Nov.
2
COVID-19 in patients with sickle cell disease - a case series from a UK Tertiary Hospital.镰状细胞病患者的新型冠状病毒肺炎——来自英国一家三级医院的病例系列
Haematologica. 2020 Nov 1;105(11):2691-2693. doi: 10.3324/haematol.2020.254250.
3
Challenges in the Management of Sickle Cell Disease During SARS-CoV-2 Pandemic.
镰状细胞病合并 COVID-19 导致的高溶血性贫血综合征 1 例。
Transfus Apher Sci. 2023 Aug;62(4):103712. doi: 10.1016/j.transci.2023.103712. Epub 2023 Apr 13.
4
Clinical and laboratory profile and outcomes of hospitalized COVID-19 patients with type 2 diabetes mellitus in Ghana - A single-center study.加纳住院 COVID-19 合并 2 型糖尿病患者的临床和实验室特征及转归：一项单中心研究。
Endocrinol Diabetes Metab. 2023 Jan;6(1):e391. doi: 10.1002/edm2.391. Epub 2022 Nov 25.
5
COVID- 19 and sickle cell disease: autopsy findings of three deaths at the 37 Military Hospital, Accra, Ghana.COVID-19 与镰状细胞病：加纳阿克拉 37 军医院三例死亡的尸检结果。
Pan Afr Med J. 2022 Apr 25;41:332. doi: 10.11604/pamj.2022.41.332.30035. eCollection 2022.
6
Clinical outcomes of COVID-19 in patients with sickle cell disease and sickle cell trait: A critical appraisal of the literature.镰状细胞病和镰状细胞性状患者感染新型冠状病毒肺炎的临床结局：文献的批判性评价
Blood Rev. 2022 May;53:100911. doi: 10.1016/j.blre.2021.100911. Epub 2021 Nov 20.
7
Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals.比较镰状细胞病患者与医护人员 COVID-19 感染的临床病程。
Ann Hematol. 2021 Sep;100(9):2195-2202. doi: 10.1007/s00277-021-04549-1. Epub 2021 May 25.
SARS-CoV-2 大流行期间镰状细胞病管理面临的挑战。
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620955240. doi: 10.1177/1076029620955240.
4
Sickle cell disease and COVID-19: Atypical presentations and favorable outcomes.镰状细胞病与2019冠状病毒病：非典型表现及良好预后
EJHaem. 2020 Aug 4;1(1):338-341. doi: 10.1002/jha2.74. eCollection 2020 Jul.
5
Current Overview on Hypercoagulability in COVID-19.新型冠状病毒肺炎患者高凝状态的研究现状。
Am J Cardiovasc Drugs. 2020 Oct;20(5):393-403. doi: 10.1007/s40256-020-00431-z.
6
Vulnerability of sickle cell disease persons to the COVID-19 in sub-Saharan Africa.撒哈拉以南非洲地区镰状细胞病患者感染新冠病毒的易感性。
Hematology. 2020 Dec;25(1):280-282. doi: 10.1080/16078454.2020.1790842.
7
Prognosis of patients with sickle cell disease and COVID-19: a French experience.镰状细胞病患者与新冠病毒病的预后：法国的经验
Lancet Haematol. 2020 Sep;7(9):e632-e634. doi: 10.1016/S2352-3026(20)30204-0. Epub 2020 Jun 18.
8
COVID-19 and Hypercoagulable State: A New Therapeutic Perspective.COVID-19与高凝状态：一种新的治疗视角。
Arq Bras Cardiol. 2020 Jun 1;114(5):829-833. doi: 10.36660/abc.20200308.
9
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.COVID-19 皮肤表现分类：西班牙 375 例快速前瞻性全国共识研究。
Br J Dermatol. 2020 Jul;183(1):71-77. doi: 10.1111/bjd.19163. Epub 2020 Jun 10.
10
Persistent hiccups as an atypical presenting complaint of COVID-19.持续性呃逆作为 COVID-19 的非典型表现。
Am J Emerg Med. 2020 Jul;38(7):1546.e5-1546.e6. doi: 10.1016/j.ajem.2020.04.045. Epub 2020 Apr 18.